TL
Insider
Tactic Pharma LLC
Chief Executive OfficerTactic Pharma LLC (Chief Executive Officer) filed 2 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 2 sales), most often in Monopar Therapeutics Inc. (MNPR). The largest single filing was $35.0M of MNPR (550,229 sh × $63.61, as filed), executed Sep 24 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$36.2M
shares × price, as filed
Last traded
Sep 24 2025
Filed Sep 26 2025
Median ADV $24.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $36.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
MNPRRecent filings
MNPRSALE
Monopar Therapeutics Inc.
View filing →
$35.0M550,229 sh × $63.61
Exec Sep 24 2025
Filed Sep 26 2025 · 5:30 PM ET MNPRSALE Monopar Therapeutics Inc. View filing → $1.2M
33,334 sh × $35.00
Exec Apr 2 2025
Filed Apr 4 2025 · 5:30 PM ET